AstraZeneca Stock Creeps Higher on Covid-19 Vaccine Update

Options traders have been much more bullish than usual of late

Deputy Editor
Sep 30, 2021 at 10:47 AM
facebook twitter linkedin

AstraZeneca PLC (NASDAQ:AZN) is in the spotlight today, after a large U.S. trial showed the drugmaker's Covid-19 vaccine demonstrated 74% efficacy in prevent symptomatic disease. That figure increased to 83.5% in individuals aged 65 and older. In response, AstraZeneca plans to file for U.S. Food and Drug Administration (FDA) approval later this year.

AstraZeneca stock was last seen up 1.1% to trade at $60.32. The equity has been volatile as of late, rallying to a Sept. 24, annual high of $61.29, which was preceded by a steep dip that the ascending 150-day moving average was able to capture. Year-to-date, the equity is up 20.5%.  

The options pits are flashing a penchant for bullish bets. This is per AstraZeneca stock's 10-day call/put volume ratio of 10.21 at the International Securities Exchange (ISE), Cboe Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX). This ratio sits higher than 94% of readings from the past year, showing puts being picked up at a much faster-than-usual rate. 

Speculating on the security's next move with options could be a prudent play. The stock's Schaeffer's Volatility Index (SVI) of 23% stands higher than 23% of all other readings in its annual range, implying that options players are pricing in low volatility expectations at the moment. 


Minimize Risk While Maximizing Profits

There is no options strategy like this one, which consistently minimizes risk while maintaining maximum profits. Perfect for traders looking for ways to control risk, reduce losses, and increase the likelihood of success when trading calls and puts. The Schaeffer’s team has over 41 years of options trading success targeting +100% gains on every trade. Rest assured your losses are effectively limited to your initial cost at the time of making your move! Don't waste another second... join us right now before the next trade is released! 



Special Offers from Schaeffer's Trading Partners